A GLP-1 weight loss program uses FDA-approved medications such as semaglutide (Ozempic®/Wegovy®) or tirzepatide (Mounjaro®) to support sustainable weight loss by regulating appetite and improving blood sugar control. GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural hormone in the body that helps reduce hunger, slow digestion, and increase feelings of fullness, making it easier to adopt healthier eating habits. When combined with lifestyle changes like balanced nutrition, regular exercise, and medical supervision, GLP-1 therapy can lead to significant and long-term weight loss. This program is ideal for individuals struggling with obesity or weight-related health conditions who haven’t achieved results through diet and exercise alone.
Please reach us at azaleamedspatn@outlook.com if you cannot find an answer to your question.
They work by:
Adults with:
They are given by weekly subcutaneous injections, typically in the stomach, thigh, or upper arm.
Weight loss varies by individual, but many people begin noticing changes within 4–8 weeks, with continued progress over several months.
Common side effects include:
Yes. GLP-1 therapy works best when combined with nutritional changes, physical activity, and behavioral support. It’s not a magic solution but a powerful tool.
It can be. For ongoing success, many patients stay on therapy long-term or as maintenance, especially if weight is regained when stopping.
No. It’s not recommended for individuals with:
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.